SMTL ID : 5ngf.2 (1 other biounit)

Crystal structure of USP7 in complex with the covalent inhibitor, FT827

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.33 Å

Oligo State

monomer

Ligands

1 x 8WN: ~{N}-[2-[4-[4-[(1-methyl-4-oxidanylidene-pyrazolo[3,4-d]pyrimidin-5-yl)methyl]-4-oxidanyl-piperidin-1-yl]carbonylphenyl]phenyl]ethanesulfonamide(Covalent)

8WN.1: 18 residues within 4Å: Chain A: C.18, Y.19, M.87, D.90, V.91, Q.92, Q.200, L.201, M.202, R.203, F.204, M.205, N.255, H.256, G.257, G.258, Y.260, Y.309 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:M.87, A:V.91, A:F.204, A:F.204, A:H.256, A:Y.309 Hydrogen bonds: A:D.90, A:V.91, A:Q.92, A:Q.92, A:R.203, A:F.204, A:N.255, A:G.257, A:Y.260

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Turnbull, A.P. et al., Molecular basis of USP7 inhibition by selective small-molecule inhibitors. Nature (2017)

Release Date

2017-10-18

Peptides

Ubiquitin carboxyl-terminal hydrolase 7: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Ubiquitin carboxyl-terminal hydrolase 7

Related Entries With Identical Sequence